article thumbnail

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

Health Populi

That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.

article thumbnail

What Person-Centered Interoperability Looks Like: Seqster

Health Populi

This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why CES 2022 Will Be Keynoted by a Health Care Executive

Health Populi

That a pharmaceutical company executive is speaking on the main stage at CES speaks to the category’s mainstreaming beyond elite athletes and smartwatches that track activity.

article thumbnail

McKinsey’s Six Shifts To Add Life to Years — and One More to Consider

Health Populi

To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies.

article thumbnail

The Top Patient Safety Risks in 2025 Are Mostly About the “Human OS” – Reading ECRI’s Annual Report

Health Populi

Each year, ECRI (the ECRI Institute) publishes an annual report on the Top 10 Patient Safety Concerns for the year. The 2025 list was published today. My read of it is that most of these risks have to do with what I’ve been referring to as the Human OS, the Human Operating System, in my talks and teachings.

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. & LONDON–(BUSINESS WIRE)– The Committee to Restore Nymox Shareholder Value, Inc.

article thumbnail

SoundHealth Receives $7 Million Seed-Round Funding and Launches SONU, the World’s First FDA-Authorized, AI-Enabled, Wearable Device for Treating Nasal Congestion Due to Allergic and Non-Allergic Rhinitis

Digital Health Global

SONU is the first over-the-counter device authorized for at-home use that extends the toolbox of treatment options for patients and physicians and offers a safe alternative to pharmaceutical treatments SAN FRANCISCO–(BUSINESS WIRE)– SoundHealth, Inc.